205 related articles for article (PubMed ID: 2014782)
1. Dysmegakaryopoiesis resembling acute megakaryoblastic leukemia in treated acute myeloid leukemia.
Rosenthal NS; Farhi DC
Am J Clin Pathol; 1991 Apr; 95(4):556-60. PubMed ID: 2014782
[TBL] [Abstract][Full Text] [Related]
2. A case of acute megakaryoblastic leukaemia (FAB M7), a rare type of acute myeloid leukemia (AML), in a teenager.
Olatunji PO; Ojo OT; Bello FO; Bakare BY; Olatunji AO
Malawi Med J; 2018 Dec; 30(4):298-301. PubMed ID: 31798811
[TBL] [Abstract][Full Text] [Related]
3. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
4. The use of the anti-factor VIII method on trephine biopsies of the bone marrow for the identification of immature and atypical megakaryocytes in myeloproliferative diseases and allied disorders. A morphometric study.
Thiele J; Krech R; Wienhold S; Simon KG; Zankovich R; Fischer R
Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 54(2):89-97. PubMed ID: 2892311
[TBL] [Abstract][Full Text] [Related]
5. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.
Barnard DR; Alonzo TA; Gerbing RB; Lange B; Woods WG;
Pediatr Blood Cancer; 2007 Jul; 49(1):17-22. PubMed ID: 16856158
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML) with myelofibrosis.
Imbert M; Nguyen D; Sultan C
Leuk Res; 1992; 16(1):51-4. PubMed ID: 1732672
[TBL] [Abstract][Full Text] [Related]
7. Acute megakaryoblastic leukemia.
Gassmann W; Löffler H
Leuk Lymphoma; 1995; 18 Suppl 1():69-73. PubMed ID: 7496359
[TBL] [Abstract][Full Text] [Related]
8. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies].
Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F
Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis.
Bae E; Park CJ; Cho YU; Seo EJ; Chi HS; Jang S; Lee KH; Lee JH; Lee JH; Suh JJ; Im HJ
Int J Lab Hematol; 2013 Dec; 35(6):629-36. PubMed ID: 23693053
[TBL] [Abstract][Full Text] [Related]
10. p-Iodophenol-enhanced luminol chemiluminescent assay applied to discrimination between acute lymphoblastic and minimally differentiated acute myeloid (FAB-M0) or acute megakaryoblastic (FAB-M7) leukemias.
da Costa M; Ximenes VF; Brunetti IL; Falcão RP; da Fonseca LM
Hematol J; 2004; 5(6):496-9. PubMed ID: 15570291
[TBL] [Abstract][Full Text] [Related]
11. Erythroblastic and/or megakaryocytic dysplasia in de novo acute myeloid leukemias M0-M5 show relation to myelodysplastic syndromes and delimit two main categories.
Lemez P; Gáliková J; Haas T
Leuk Res; 2000 Mar; 24(3):207-15. PubMed ID: 10739003
[TBL] [Abstract][Full Text] [Related]
12. Leukemic blasts with markers of four cell lineages in Down's syndrome ("megakaryoblastic leukemia").
Slørdahl SH; Smeland EB; Holte H; Grønn M; Lie SO; Seip M
Med Pediatr Oncol; 1993; 21(4):254-8. PubMed ID: 8469219
[TBL] [Abstract][Full Text] [Related]
13. [Poor response in patients with de novo acute myeloid leukemia and erythroblastic or megakaryocytic dysplasia to treatment with standard doses of cytosine arabinoside and daunorubicin].
Lemez P; Gáliková J; Haas T
Vnitr Lek; 1999 Jun; 45(6):342-6. PubMed ID: 11045169
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotyping of AML and MDS and detection of residual disease.
Sanz MA; Sempere A
Baillieres Clin Haematol; 1996 Mar; 9(1):35-55. PubMed ID: 8730550
[TBL] [Abstract][Full Text] [Related]
15. [Evolution to megakaryoblastic leukemia observed in myelodysplastic syndrome with erythrolekemia-like features].
Takai K; Sanada M; Shibuya H
Rinsho Ketsueki; 1992 Aug; 33(8):1071-6. PubMed ID: 1404864
[TBL] [Abstract][Full Text] [Related]
16. CD34+ megakaryoblastic leukaemic cells are CD38-, but CD61+ and glycophorin A+: improved criteria for diagnosis of AML-M7?
Helleberg C; Knudsen H; Hansen PB; Nikolajsen K; Kjaersgaard E; Ralfkiaer E; Johnsen HE
Leukemia; 1997 Jun; 11(6):830-4. PubMed ID: 9177436
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
Langebrake C; Creutzig U; Reinhardt D
Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
19. Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia.
Lee JH; Choi SJ; Lee JH; Park JH; Kim H; Joo YD; Lee WS; Zang DY; Kim HJ; Lee KH;
Ann Hematol; 2006 Jun; 85(6):357-65. PubMed ID: 16575580
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural studies of the megakaryoblastic leukemias of Down syndrome.
Zipursky A; Christensen H; De Harven E
Leuk Lymphoma; 1995 Jul; 18(3-4):341-7. PubMed ID: 8535203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
